300463 Stock Overview
Engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Maccura Biotechnology Co.Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.73 |
| 52 Week High | CN¥17.38 |
| 52 Week Low | CN¥9.90 |
| Beta | 0.33 |
| 11 Month Change | 4.45% |
| 3 Month Change | -10.73% |
| 1 Year Change | -23.13% |
| 33 Year Change | -66.15% |
| 5 Year Change | -48.51% |
| Change since IPO | -12.59% |
Recent News & Updates
Is Maccura BiotechnologyLtd (SZSE:300463) Using Too Much Debt?
Aug 01
Many Still Looking Away From Maccura Biotechnology Co.Ltd (SZSE:300463)
May 28Shareholder Returns
| 300463 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | 5.3% | 7.8% | 0.8% |
| 1Y | -23.1% | -38.0% | -21.0% |
Return vs Industry: 300463 exceeded the CN Life Sciences industry which returned -40.2% over the past year.
Return vs Market: 300463 underperformed the CN Market which returned -19.9% over the past year.
Price Volatility
| 300463 volatility | |
|---|---|
| 300463 Average Weekly Movement | 4.1% |
| Life Sciences Industry Average Movement | 6.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 300463 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300463's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 3,362 | Wu Mingjian | www.maccura.com |
Maccura Biotechnology Co Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally. The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, coagulation, special protein, cardiac, and lipids; and clinical laboratory products, such as automatic hematology, and automatic and semi-automatic coagulation analyzers.
Maccura Biotechnology Co.Ltd Fundamentals Summary
| 300463 fundamental statistics | |
|---|---|
| Market cap | CN¥7.12b |
| Earnings (TTM) | CN¥339.51m |
| Revenue (TTM) | CN¥2.79b |
21.0x
P/E Ratio2.5x
P/S RatioIs 300463 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300463 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.79b |
| Cost of Revenue | CN¥1.23b |
| Gross Profit | CN¥1.57b |
| Other Expenses | CN¥1.23b |
| Earnings | CN¥339.51m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.56 |
| Gross Margin | 56.11% |
| Net Profit Margin | 12.15% |
| Debt/Equity Ratio | 12.0% |
How did 300463 perform over the long term?
See historical performance and comparison